Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001079973-25-001813 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-20 | 2025-11-18 | STLN | Pacala Mark L | Dir | S - Sale | $4.00 | -50.0K | 221.6K | -18% | -$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-18 | S | D | 46,630 | $4.00 | 174,971 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-18 | S | D | 2,160 | $4.00 | 222,811 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-18 | S | D | 1,210 | $4.00 | 221,601 | D | — | — |